Logotype for Tilray Brands Inc

Tilray Brands (TLRY) Q3 2026 earnings summary

Event summary combining transcript, slides, and related documents.

Logotype for Tilray Brands Inc

Q3 2026 earnings summary

9 Apr, 2026

Executive summary

  • Achieved record Q3 net revenue of $206.7 million, up 11% year-over-year, driven by cannabis, distribution, and wellness growth, with BrewDog acquisition and Carlsberg partnership positioning annualized revenue at $1.2 billion.

  • Operating expenses decreased significantly due to the absence of prior year non-cash impairment charges and lower amortization, selling, litigation, and restructuring costs.

  • Adjusted EBITDA rose 19% to $10.7 million, reflecting improved operating performance and cost discipline.

  • Maintained strong liquidity with $265 million in cash and marketable securities and a net cash position of $3.5 million.

  • Diversified global platform includes leading positions in cannabis (Canada), craft brewing (U.S. and U.K.), medical cannabis, and wellness.

Financial highlights

  • Net revenue reached $206.7 million, up 11% year-over-year; gross profit was $55 million, up 6%; gross margin was 27%.

  • Cannabis net revenue grew 19% to $64.8 million; international cannabis sales up 73% year-over-year; gross margin at 40%.

  • Distribution net revenue increased 35% to $83 million; wellness net revenue up 16% to $16.4 million; beverage net revenue was $42.6 million, down 24% year-over-year.

  • Net loss was $25.2 million, a significant improvement from $793.5 million prior year, mainly due to non-cash impairments.

  • Adjusted net income was $2.4 million, up from an adjusted net loss of $2.9 million; adjusted cash operating income improved to $4.1 million.

Outlook and guidance

  • Fiscal 2026 adjusted EBITDA guidance reaffirmed at $62 million–$72 million, representing 13% to 31% growth over fiscal 2025.

  • Management focused on revenue growth, margin improvement, and positive cash flow, with continued investment in core brands and international expansion.

  • Guidance excludes stock-based compensation, impairments, litigation, restructuring, and other non-recurring items.

  • Expect continued momentum in international cannabis and beverage segments, with further operational efficiencies and cost savings from ongoing integration and scale.

  • Management monitoring Middle East hostilities for potential impacts on expenses and supply chain.

Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.
All investor relations material. One API.
Learn more